Press release
mRNA Platform Market worth $154.82 billion by 2030, growing at a CAGR of 51.63% - Exclusive Report by 360iResearch
mRNA Platform Market | 360iResearch
The Global mRNA Platform Market to grow from USD 8.40 billion in 2023 to USD 154.82 billion by 2030, at a CAGR of 51.63%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/mrna-platform?utm_source=openpr&utm_medium=referral&utm_campaign=sample
The mRNA (messenger RNA) platform is a revolutionary biotechnological framework for developing genetic-based therapies and vaccines. This platform leverages messenger RNA molecules to instruct cells to produce specific proteins that can prevent, treat, or cure diseases. The scope of the mRNA platform market includes research and development (R&D), manufacturing, distribution, and the provision of mRNA-based products. It consists of various stakeholders, including pharmaceutical companies, biotech firms, medical research institutions, healthcare providers, and regulatory bodies. This technology has revolutionized treatment approaches for diseases such as infectious diseases, cancer, and genetic disorders and gained prominence with the rapid development of COVID-19 vaccines. The growth is fueled by technological advancements, significant R&D investment, fast-tracked regulatory approvals, and strong collaborations between industry and academia. Key opportunities emerge in expanding new therapeutic areas, personalized medicine, improvements in delivery systems, and access in underserved regions. However, the market faces challenges such as stringent cold chain logistics, public disbelief, manufacturing complexities, and regulatory barriers. Innovations such as non-viral delivery vehicles, developing thermostable mRNA formulations, refining targeting mechanisms, reducing treatment costs, and implementing digital tools for therapy monitoring pose significant future business opportunities. These innovations are expected to propel the market forward by addressing current limitations and broadening the reach and efficacy of mRNA-based solutions.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the mRNA Platform Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the mRNA Platform Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the mRNA Platform Market, highlighting leading vendors and their innovative profiles. These include Argos Therapeutics, Inc., AstraZeneca plc., BioNTech SE, CRISPR Therapeutics AG, CureVac N.V., Dicerna Pharmaceuticals, Inc by Novo Nordisk A/S, eTheRNA, ethris GmbH, In-Cell-Art, Merck & Co., Inc., Moderna, Inc., Pfizer Inc., Regulus Therapeutics Inc., Sangamo Therapeutics, Inc., Sanofi S.A., and Tiba Biotech LLC.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/mrna-platform?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the mRNA Platform Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Indication, market is studied across Autoimmune Diseases, Cancer, Infectious Diseases, Rare Diseases, and Respiratory Diseases. The Cancer is further studied across Personalized Treatment and Single Cancer Focussed. The Infectious Diseases is projected to witness significant market share during forecast period.
Based on Usability, market is studied across Prophylactic Vaccines, Therapeutic Drugs, and Therapeutic Vaccines. The Therapeutic Drugs is projected to witness significant market share during forecast period.
Based on mRNA Type, market is studied across Nucleoside-Modified mRNA, Self-Amplifying mRNA, and Unmodified mRNA. The Nucleoside-Modified mRNA is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Hospitals & Clinics, Pharmaceutical Companies, and Research Organization. The Hospitals & Clinics is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. mRNA Platform Market, by Indication
7. mRNA Platform Market, by Usability
8. mRNA Platform Market, by mRNA Type
9. mRNA Platform Market, by End-User
10. Americas mRNA Platform Market
11. Asia-Pacific mRNA Platform Market
12. Europe, Middle East & Africa mRNA Platform Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the mRNA Platform Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the mRNA Platform Market?
3. What is the competitive strategic window for opportunities in the mRNA Platform Market?
4. What are the technology trends and regulatory frameworks in the mRNA Platform Market?
5. What is the market share of the leading vendors in the mRNA Platform Market?
6. What modes and strategic moves are considered suitable for entering the mRNA Platform Market?
Read More @ https://www.360iresearch.com/library/intelligence/mrna-platform?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Platform Market worth $154.82 billion by 2030, growing at a CAGR of 51.63% - Exclusive Report by 360iResearch here
News-ID: 3364496 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
